- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02031497
Comparison of the Effects of a 12-Week Consumption of Two Carbonated Beverages on Insulin Sensitivity (SEDULC)
March 2, 2017 updated by: Institute For European Expertise in Physiology
The purpose of this study is to determine whether consumption of carbonated drinks containing sweeteners affect insulin sensitivity.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Sweeteners are natural or synthetic sugar substitutes which provide a sweetness taste to drink and food with few or no additional calories.
Sweeteners are widely used in commercialized beverages.
Despite some debate, no significant toxicity was demonstrated at a reasonable level of consumption (less than 20 cans per day).
However little data is available on the metabolic effects of a regular consumption of beverages containing sweeteners.
The objective of the study is to evaluate the effect of a regular consumption (twice a day for 12 weeks) of a carbonated drink with sweeteners, in a normal diet, compared with unsweetened sparkling water on insulin sensitivity in healthy normoweight and overweight subjects.
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Rennes, France, 35033 Rennes Cedex 9
- Unit of Clinical Investigation,Centre Hospitalo-Universitaire de Rennes
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 50 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Healthy male or female
- Subject taking at least three main meals (breakfast, lunch, dinner)
- Subject able to understand and sign an informed consent
- Subject drinking and enjoying soft drinks
- Subject appreciating sweeteners taste
- 19 kg/m² < BMI< 30 kg/m²
Exclusion Criteria:
- Any severe or acute illness that may influence the results of the study or may be life-threatening
- Pregnant or breastfeeding subject
- Past or present metabolic or digestive diseases, with the exception of a possible appendectomy
- Diabetes or severe acute illness that may alter blood sugar
- Treatment that may interfere with glucose homeostasis
- Past or present kidney disease (renal failure, ... )
- Local or systemic medication that may change water status, metabolism and feeding behavior
- Antiplatelet treatment
- Alcohol consumption ≥ 3-4 glasses / day ( ≥ 21 drinks / week )
- Sustained physical exercise (more than 4 hours per week)
- Subject adding sweeteners (tablets or powder) in their diet
- Subject drinking more than two cans of drinks with sweeteners / day
- Subject dieting to lose weight
- Subject unable or unwilling to consume 2 liters of fluid / day
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Drink with sweeteners
|
Subjects will have to consume a 330ml can of a drink with sweeteners twice per day as part of their usual fluid intake for 12 weeks.
Subjects will have to consume a 330ml can of a drink without sweeteners twice per day as part of their usual fluid intake for 12 weeks.
|
Active Comparator: Drink without sweeteners
|
Subjects will have to consume a 330ml can of a drink with sweeteners twice per day as part of their usual fluid intake for 12 weeks.
Subjects will have to consume a 330ml can of a drink without sweeteners twice per day as part of their usual fluid intake for 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Matsuda Insulin sensitivity Index
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Insulinogenic Index defined as ∆ insulin 0-30 / ∆ glucose 0-30
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
Disposition index defined as Insulin sensitivity x insulinogenic Index
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
HOMA-IR Index defined as fasting Glycemia x fasting insulinemia/22.5
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
Dietary intake
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
Physical activity
Time Frame: Before and after each of the two 12-week intervention period
|
Before and after each of the two 12-week intervention period
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Fabrice Bonnet, MD, PhD, Centre Hospitalo-Universitaire de Rennes
- Study Director: Fabrice Lainé, MD, PhD, Centre Hospitalo-Universitaire de Rennes
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2012
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
January 8, 2014
First Submitted That Met QC Criteria
January 8, 2014
First Posted (Estimate)
January 9, 2014
Study Record Updates
Last Update Posted (Actual)
March 3, 2017
Last Update Submitted That Met QC Criteria
March 2, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- 2012EL0905SEDULC
- 120901-10 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Glucose Homeostasis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationCompletedGlucose HomeostasisSwitzerland
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
Rigshospitalet, DenmarkCompletedPostprandial Glucose HomeostasisDenmark
-
Wageningen UniversityCompletedInflammation | Glucose Tolerance | Lipid Homeostasis | Vascular FunctionNetherlands
-
Glostrup University Hospital, CopenhagenUniversity of Copenhagen; European Foundation for the Study of DiabetesCompletedInsulin Resistance | Inactivity | Deteriorated Glucose HomeostasisDenmark
-
Tulane University Health Sciences CenterCompletedObesity | Glucose Homeostasis | Postmenopausal SymptomsUnited States
-
Chinese Academy of Medical Sciences, Fuwai HospitalCompletedCardiac Surgery | HomeostasisChina
-
Chengdu Maternal and Children's Health Care HospitalCompletedIron Metabolic Homeostasis
-
National Institute of Environmental Health Sciences...CompletedGlucose Homeostasis | Lipid Metabolism | Respiratory Function | Protein Metabolism | Connective Tissue MetabolismUnited States
-
TakedaCompleted
Clinical Trials on Drink with sweeteners
-
Monell Chemical Senses CenterCompleted
-
Northumbria UniversityWithdrawnBlood Glucose | Appetite | Intestinal Absorption | Nutrient Sensing | Taste ReceptorsUnited Kingdom
-
University Hospital, GrenobleRecruitingNon Nutritive Sweeteners ConsumptionFrance
-
Centro Universitário UnivatesCompleted
-
University of AarhusCompleted
-
The Coca-Cola CompanyCreaBIOCompletedEating BehaviorFrance
-
Arizona State UniversityKraft Heinz CompanyRecruiting
-
Sahlgrenska University Hospital, SwedenCompleted
-
University of AarhusCompleted
-
Centro Universitário UnivatesCompleted